(19)
(11) EP 4 739 711 A1

(12)

(43) Date of publication:
13.05.2026 Bulletin 2026/20

(21) Application number: 24835186.8

(22) Date of filing: 11.06.2024
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
A61K 39/00(2006.01)
 C12N 15/10(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/2881; C07K 2317/569; C07K 2317/52; C07K 16/2863; C07K 2317/92; C07K 2317/22; C07K 2317/77; C07K 2317/24; C07K 2317/565; C07K 2317/64; C07K 2317/31; C07K 16/18; A61K 2039/505; C07K 2319/30
(86) International application number:
PCT/CN2024/098331
(87) International publication number:
WO 2025/007703 (09.01.2025 Gazette 2025/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 04.07.2023 WO PCT/CN2023/105681

(71) Applicant: Beijing Neox Biotech Limited
Beijing 102206 (CN)

(72) Inventors:
  • WU, Ran
    Beijing 102206 (CN)
  • GUO, Jianxiu
    Beijing 102206 (CN)
  • ZHANG, Fei
    Beijing 102206 (CN)
  • GUO, Bingshi
    Beijing 102206 (CN)
  • ZHENG, Xin
    Beijing 102206 (CN)
  • CHEN, Mingchen
    Beijing 102206 (CN)

(74) Representative: CMS Cameron McKenna Nabarro Olswang LLP 
Cannon Place 78 Cannon Street
London EC4N 6AF
London EC4N 6AF (GB)

   


(54) ANTI-TFR1 ANTIBODIES AND USES THEREOF